3FL7 - JenaLib

Asymmetric Unit (Jmol Viewer)

Asym. Unit - sites (Jmol Viewer)

Biological Unit 1 (Jmol Viewer)

Biol. Unit 1 - sites (Jmol Viewer)

Biological Unit 2 (Jmol Viewer)

Title :   CRYSTAL STRUCTURE OF THE HUMAN EPHRIN A2 ECTODOMAIN

Authors :   J. R. Walker, L. Yermekbayeva, A. Seitova, C. Butler-Cole, C. Bountra, J. Weigelt, C. H. Arrowsmith, A. M. Edwards, A. Bochkarev, S. Dhe-Paga Structural Genomics Consortium (Sgc)

Date :   18 Dec 08 (Deposition) - 27 Jan 09 (Release) - 13 Jul 11 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   2.50

Chains :   Asym. Unit : A
Biol. Unit 1: A  (2x)
Biol. Unit 2: A  (1x)

Keywords :   Atp-Binding, Kinase, Nucleotide-Binding, Receptor, Transferase, Phosphorylation, Transmembrane, Tyrosine-Protein Kinase, Glycoprotein, Ligand Binding Domain, Cysteine-Rich Domain, Sushi Domain, Egf-Like Motif, Fibronectin Domain, Structural Genomics Consortium, Sgc, Membrane, Phosphoprotein, Signaling Protein (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   J. P. Himanen, L. Yermekbayeva, P. W. Janes, J. R. Walker, K. Xu, L. Atapattu, K. R. Rajashankar, A. Mensinga, M. Lackmann, D. B. Nikolov, S. Dhe-Paganon
Architecture Of Eph Receptor Clusters.
Proc. Natl. Acad. Sci. Usa V. 107 10860 2010
PubMed-ID: 20505120 | Reference-DOI: 10.1073/PNAS.1004148107
(for further references see the PDB file header)

Molecule 1 - EPHRIN RECEPTOR
	Chains	:	A
	EC Number	:	2.7.10.1
	Engineered	:	YES
	Expression System	:	SPODOPTERA FRUGIPERDA
	Expression System Plasmid	:	PFHMSP-LIC-N
	Expression System Strain	:	SF9
	Expression System Taxid	:	7108
	Expression System Vector	:	BACULOVIRUS
	Expression System Vector Type	:	PLASMID
	Fragment	:	ECTODOMAIN, UNP RESIDUES 23-531
	Gene	:	ECK, EPHA2, HCG_24712, RP11-276H7.1-001
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606

		1
Asymmetric Unit	:	A
Biological Unit 1 (2x)	:	A
Biological Unit 2 (1x)	:	A

Summary Information (see also Sequences/Alignments below)

Asymmetric Unit (3, 5)

No.	Name	Count	Type	Full Name
1	CL	3	Ligand/Ion	CHLORIDE ION
2	NA	1	Ligand/Ion	SODIUM ION
3	NAG	1	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE

Biological Unit 1 (1, 2)

No.	Name	Count	Type	Full Name
1	CL	-1	Ligand/Ion	CHLORIDE ION
2	NA	-1	Ligand/Ion	SODIUM ION
3	NAG	2	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE

Biological Unit 2 (1, 1)

No.	Name	Count	Type	Full Name
1	CL	-1	Ligand/Ion	CHLORIDE ION
2	NA	-1	Ligand/Ion	SODIUM ION
3	NAG	1	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE

Asymmetric Unit (4, 4)

No.	Name	Evidence	Residues	Description
1	AC1	SOFTWARE	ASP A:143 , ASP A:148 , GLU A:166	BINDING SITE FOR RESIDUE NA A1001
2	AC2	SOFTWARE	LYS A:468 , ARG A:486	BINDING SITE FOR RESIDUE CL A1003
3	AC3	SOFTWARE	GLY A:171	BINDING SITE FOR RESIDUE CL A1004
4	AC4	SOFTWARE	ASN A:407 , THR A:409 , SER A:431	BINDING SITE FOR RESIDUE NAG A1005

Asymmetric Unit

No.	Residues
1	A:70	-	A:188
2	A:105	-	A:115
3	A:201	-	A:247
4	A:230	-	A:260
5	A:262	-	A:273
6	A:276	-	A:290
7	A:293	-	A:307
8	A:309	-	A:325
9	A:366	-	A:379
10	A:369	-	A:376

Asymmetric Unit

No.	Residues
1	His A:46	-	Pro A:47
2	Gly A:171	-	Pro A:172

Asymmetric Unit (3, 3)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_055989	K	99	N	EPHA2_HUMAN	Polymorphism	1058372	A	K	99	N
2	UniProt	VAR_042121	G	391	R	EPHA2_HUMAN	Polymorphism	34192549	A	G	391	R
3	UniProt	VAR_042122	T	511	M	EPHA2_HUMAN	Polymorphism	55747232	A	T	511	M

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (3, 6)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_055989	K	99	N	EPHA2_HUMAN	Polymorphism	1058372	A	K	99	N
2	UniProt	VAR_042121	G	391	R	EPHA2_HUMAN	Polymorphism	34192549	A	G	391	R
3	UniProt	VAR_042122	T	511	M	EPHA2_HUMAN	Polymorphism	55747232	A	T	511	M

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 2 (3, 3)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_055989	K	99	N	EPHA2_HUMAN	Polymorphism	1058372	A	K	99	N
2	UniProt	VAR_042121	G	391	R	EPHA2_HUMAN	Polymorphism	34192549	A	G	391	R
3	UniProt	VAR_042122	T	511	M	EPHA2_HUMAN	Polymorphism	55747232	A	T	511	M

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric Unit (4, 5)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	EPH_LBD	PS51550	Eph receptor ligand-binding domain profile.	EPHA2_HUMAN	28-206	1	A:28-206
2	RECEPTOR_TYR_KIN_V_1	PS00790	Receptor tyrosine kinase class V signature 1.	EPHA2_HUMAN	182-202	1	A:182-202
3	RECEPTOR_TYR_KIN_V_2	PS00791	Receptor tyrosine kinase class V signature 2.	EPHA2_HUMAN	247-267	1	A:247-267
4	FN3	PS50853	Fibronectin type-III domain profile.	EPHA2_HUMAN	438-529 328-432	2	A:438-528 A:328-432

Biological Unit 1 (4, 10)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	EPH_LBD	PS51550	Eph receptor ligand-binding domain profile.	EPHA2_HUMAN	28-206	2	A:28-206
2	RECEPTOR_TYR_KIN_V_1	PS00790	Receptor tyrosine kinase class V signature 1.	EPHA2_HUMAN	182-202	2	A:182-202
3	RECEPTOR_TYR_KIN_V_2	PS00791	Receptor tyrosine kinase class V signature 2.	EPHA2_HUMAN	247-267	2	A:247-267
4	FN3	PS50853	Fibronectin type-III domain profile.	EPHA2_HUMAN	438-529 328-432	4	A:438-528 A:328-432

Biological Unit 2 (4, 5)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	EPH_LBD	PS51550	Eph receptor ligand-binding domain profile.	EPHA2_HUMAN	28-206	1	A:28-206
2	RECEPTOR_TYR_KIN_V_1	PS00790	Receptor tyrosine kinase class V signature 1.	EPHA2_HUMAN	182-202	1	A:182-202
3	RECEPTOR_TYR_KIN_V_2	PS00791	Receptor tyrosine kinase class V signature 2.	EPHA2_HUMAN	247-267	1	A:247-267
4	FN3	PS50853	Fibronectin type-III domain profile.	EPHA2_HUMAN	438-529 328-432	2	A:438-528 A:328-432

Asymmetric Unit (8, 8)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1a	ENST00000358432	1a	ENSE00001954971	chr1:16482582-16482343	240	EPHA2_HUMAN	1-29	29	1	A:25-29	5
1.2	ENST00000358432	2	ENSE00000827996	chr1:16477458-16477391	68	EPHA2_HUMAN	29-51	23	1	A:29-51	23
1.3	ENST00000358432	3	ENSE00001031821	chr1:16475542-16474873	670	EPHA2_HUMAN	52-275	224	1	A:52-275 (gaps)	224
1.5	ENST00000358432	5	ENSE00000827994	chr1:16464925-16464770	156	EPHA2_HUMAN	275-327	53	1	A:275-327	53
1.6	ENST00000358432	6	ENSE00000955420	chr1:16464680-16464348	333	EPHA2_HUMAN	327-438	112	1	A:327-438 (gaps)	112
1.7	ENST00000358432	7	ENSE00000955397	chr1:16462265-16462150	116	EPHA2_HUMAN	438-476	39	1	A:438-476 (gaps)	39
1.8	ENST00000358432	8	ENSE00001031787	chr1:16461684-16461531	154	EPHA2_HUMAN	477-528	52	1	A:479-528 (gaps)	50
1.9b	ENST00000358432	9b	ENSE00001031795	chr1:16461062-16460963	100	EPHA2_HUMAN	528-561	34	1	A:528-528	1
1.10	ENST00000358432	10	ENSE00000955400	chr1:16460410-16460355	56	EPHA2_HUMAN	561-580	20	0	-	-
1.11a	ENST00000358432	11a	ENSE00001031771	chr1:16460101-16459976	126	EPHA2_HUMAN	580-622	43	0	-	-
1.12a	ENST00000358432	12a	ENSE00000955402	chr1:16459863-16459675	189	EPHA2_HUMAN	622-685	64	0	-	-
1.13	ENST00000358432	13	ENSE00000955403	chr1:16458934-16458873	62	EPHA2_HUMAN	685-705	21	0	-	-
1.14	ENST00000358432	14	ENSE00000955404	chr1:16458768-16458559	210	EPHA2_HUMAN	706-775	70	0	-	-
1.15	ENST00000358432	15	ENSE00000955405	chr1:16458365-16458216	150	EPHA2_HUMAN	776-825	50	0	-	-
1.16	ENST00000358432	16	ENSE00000955406	chr1:16456914-16456721	194	EPHA2_HUMAN	826-890	65	0	-	-
1.17	ENST00000358432	17	ENSE00001031824	chr1:16456084-16455929	156	EPHA2_HUMAN	890-942	53	0	-	-
1.18b	ENST00000358432	18b	ENSE00001840165	chr1:16451815-16450832	984	EPHA2_HUMAN	942-976	35	0	-	-

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:482
 aligned with EPHA2_HUMAN | P29317 from UniProtKB/Swiss-Prot  Length:976

    Alignment length:504
                                    34        44        54        64        74        84        94       104       114       124       134       144       154       164       174       184       194       204       214       224       234       244       254       264       274       284       294       304       314       324       334       344       354       364       374       384       394       404       414       424       434       444       454       464       474       484       494       504       514       524    
          EPHA2_HUMAN    25 QGKEVVLLDFAAAGGELGWLTHPYGKGWDLMQNIMNDMPIYMYSVCNVMSGDQDNWLRTNWVYRGEAERIFIELKFTVRDCNSFPGGASSCKETFNLYYAESDLDYGTNFQKRLFTKIDTIAPDEITVSSDFEARHVKLNVEERSVGPLTRKGFYLAFQDIGACVALLSVRVYYKKCPELLQGLAHFPETIAGSDAPSLATVAGTCVDHAVVPPGGEEPRMHCAVDGEWLVPIGQCLCQAGYEKVEDACQACSPGFFKFEASESPCLECPEHTLPSPEGATSCECEEGFFRAPQDPASMPCTRPPSAPHYLTAVGMGAKVELRWTPPQDSGGREDIVYSVTCEQCWPESGECGPCEASVRYSEPPHGLTRTSVTVSDLEPHMNYTFTVEARNGVSGLVTSRSFRTASVSINQTEPPKVRLEGRSTTSLSVSWSIPPPQQSRVWKYEVTYRKKGDSNSYNVRRTEGFSVTLDDLAPDTTYLVQVQALTQEGQGAGSKVHEFQTLS 528
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author ..eeeeeee.hhhh.....eee......eeeee.---..eeeeeee........eeee...ee......eeeeeeeee.......----.....eeeeeeee........hhhhheeeeee........------....eeeeeee......eeeeeeee...eeeeeeeeeeeeee..eee..eee..ee........eeee.ee...ee...--...eeee.............ee...eeee..eeee....ee.........ee....ee.........ee.........................eeee.....eeeee............eeeeeeeee..-...eee.....ee..........eeeee......eeeeeeeee..hhhhh....eeeeeee.......eeeeee...-..eeeee..........eeeeeeee.--....eeeee...eee........eeeeeeeee..---.ee...eeee... Sec.struct. author
                 SAPs(SNPs) --------------------------------------------------------------------------N---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------R-----------------------------------------------------------------------------------------------------------------------M----------------- SAPs(SNPs)
                PROSITE (1) ---EPH_LBD  PDB: A:28-206 UniProt: 28-206                                                                                                                                             ----------------------------------------RECEPTOR_TYR_KIN_V_2 ------------------------------------------------------------FN3  PDB: A:328-432 UniProt: 328-432                                                                     -----FN3  PDB: A:438-528 UniProt: 438-529                                                        PROSITE (1)
                PROSITE (2) -------------------------------------------------------------------------------------------------------------------------------------------------------------RECEPTOR_TYR_KIN_V_1 -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE (2)
           Transcript 1 (1) 1.1a ----------------------Exon 1.3  PDB: A:52-275 (gaps) UniProt: 52-275                                                                                                                                                                                  ---------------------------------------------------Exon 1.6  PDB: A:327-438 (gaps) UniProt: 327-438                                                                --------------------------------------Exon 1.8  PDB: A:479-528 (gaps) UniProt: 477-528     Transcript 1 (1)
           Transcript 1 (2) ----Exon 1.2  PDB: A:29-51 -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.5  PDB: A:275-327 UniProt: 275-327            --------------------------------------------------------------------------------------------------------------Exon 1.7  PDB: A:438-476 (gaps)        ---------------------------------------------------1 Transcript 1 (2)
                 3fl7 A  25 QGKEVVLLDFAAAGGELGWLTHPYGKGWDLMQNI---MPIYMYSVCNVMSGDQDNWLRTNWVYRGEAERIFIELKFTVRDCNSFP----SCKETFNLYYAESDLDYGTNFQKRLFTKIDTIAPDEITVS------HVKLNVEERSVGPLTRKGFYLAFQDIGACVALLSVRVYYKKCPELLQGLAHFPETIAGSDAPSLATVAGTCVDHAVVPP--EEPRMHCAVDGEWLVPIGQCLCQAGYEKVEDACQACSPGFFKFEASESPCLECPEHTLPSPEGATSCECEEGFFRAPQDPASMPCTRPPSAPHYLTAVGMGAKVELRWTPPQDSGGREDIVYSVTCEQCWP-SGECGPCEASVRYSEPPHGLTRTSVTVSDLEPHMNYTFTVEARNGVSGLVTSRSFRTASVSINQTEPPKVRLEGRST-SLSVSWSIPPPQQSRVWKYEVTYRKK--SNSYNVRRTEGFSVTLDDLAPDTTYLVQVQALTQ---GAGSKVHEFQTLS 528
                                    34        44        54   |   |64        74        84        94       104    |  114       124       134       144        |-     | 164       174       184       194       204       214       224       234   |  |244       254       264       274       284       294       304       314       324       334       344       354       364      |374       384       394       404       414       424       434       444    | |454       464       474 |  |  484       494       504       | - |     524    
                                                            58  62                                            109  114                                    153    160                                                                           238  |                                                                                                                               371 |                                                                         449 |                      476  |                              512 516            
                                                                                                                                                                                                                                                  241                                                                                                                                 373                                                                           451                         479

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

(no "SCOP Domain" information available for 3FL7)

(no "CATH Domain" information available for 3FL7)

(no "Pfam Domain" information available for 3FL7)

Asymmetric Unit(hide GO term definitions)

Chain A (EPHA2_HUMAN | P29317)

molecular function
	GO:0005524	ATP binding	Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
	GO:0005003	ephrin receptor activity	Combining with an ephrin to initiate a change in cell activity.
	GO:0016301	kinase activity	Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
	GO:0000166	nucleotide binding	Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0004672	protein kinase activity	Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
	GO:0004713	protein tyrosine kinase activity	Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
	GO:0016740	transferase activity	Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
	GO:0004714	transmembrane receptor protein tyrosine kinase activity	Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
biological process
	GO:0090630	activation of GTPase activity	Any process that initiates the activity of an inactive GTPase through the replacement of GDP by GTP.
	GO:0001525	angiogenesis	Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
	GO:0006915	apoptotic process	A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
	GO:0048320	axial mesoderm formation	The process that gives rise to the axial mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
	GO:0001568	blood vessel development	The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.
	GO:0046849	bone remodeling	The continuous turnover of bone matrix and mineral that involves first, an increase in resorption (osteoclastic activity) and later, reactive bone formation (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium homeostasis. An imbalance in the regulation of bone resorption and bone formation results in many of the metabolic bone diseases, such as osteoporosis.
	GO:0060444	branching involved in mammary gland duct morphogenesis	The process in which the branching structure of the mammary gland duct is generated and organized. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk.
	GO:0007155	cell adhesion	The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
	GO:0060326	cell chemotaxis	The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
	GO:0030154	cell differentiation	The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
	GO:0016477	cell migration	The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
	GO:0048013	ephrin receptor signaling pathway	The series of molecular signals generated as a consequence of an ephrin receptor binding to an ephrin.
	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the detection of DNA damage, and ends when the execution phase of apoptosis is triggered.
	GO:0030216	keratinocyte differentiation	The process in which a relatively unspecialized cell acquires specialized features of a keratinocyte.
	GO:0070309	lens fiber cell morphogenesis	The process in which the structures of a lens fiber cell are generated and organized. This process occurs while the initially relatively unspecialized cell is acquiring the specialized features of a lens fiber cell. A lens fiber cell is any of the elongated, tightly packed cells that make up the bulk of the mature lens in a camera-type eye.
	GO:0033598	mammary gland epithelial cell proliferation	The multiplication or reproduction of mammary gland epithelial cells, resulting in the expansion of a cell population. Mammary gland epithelial cells make up the covering of surfaces of the mammary gland. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk.
	GO:0007275	multicellular organism development	The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
	GO:0051898	negative regulation of protein kinase B signaling	Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
	GO:0021915	neural tube development	The process whose specific outcome is the progression of the neural tube over time, from its formation to the mature structure. The mature structure of the neural tube exists when the tube has been segmented into the forebrain, midbrain, hindbrain and spinal cord regions. In addition neural crest has budded away from the epithelium.
	GO:0030182	neuron differentiation	The process in which a relatively unspecialized cell acquires specialized features of a neuron.
	GO:0060035	notochord cell development	The process whose specific outcome is the progression of a notochord cell over time, from its formation to its mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
	GO:0014028	notochord formation	The formation of the notochord from the chordamesoderm. The notochord is composed of large cells packed within a firm connective tissue sheath and is found in all chordates at the ventral surface of the neural tube. In vertebrates, the notochord contributes to the vertebral column.
	GO:0048570	notochord morphogenesis	The process in which the anatomical structures of the notochord are generated and organized. The notochord is a mesoderm-derived structure located ventral of the developing nerve cord. In vertebrates, the notochord serves as a core around which other mesodermal cells form the vertebrae. In the most primitive chordates, which lack vertebrae, the notochord persists as a substitute for a vertebral column.
	GO:0001649	osteoblast differentiation	The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone.
	GO:0030316	osteoclast differentiation	The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue.
	GO:0018108	peptidyl-tyrosine phosphorylation	The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
	GO:0016310	phosphorylation	The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
	GO:0090004	positive regulation of establishment of protein localization to plasma membrane	Any process that increases the frequency, rate or extent of the directed movement of a protein to a specific location in the plasma membrane.
	GO:0036342	post-anal tail morphogenesis	The process in which a post-anal tail is generated and organized. A post-anal tail is a muscular region of the body that extends posterior to the anus. The post-anal tail may aid locomotion and balance.
	GO:0043491	protein kinase B signaling	A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound.
	GO:0006468	protein phosphorylation	The process of introducing a phosphate group on to a protein.
	GO:0070372	regulation of ERK1 and ERK2 cascade	Any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
	GO:0045765	regulation of angiogenesis	Any process that modulates the frequency, rate or extent of angiogenesis.
	GO:0043535	regulation of blood vessel endothelial cell migration	Any process that modulates the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
	GO:0033628	regulation of cell adhesion mediated by integrin	Any process that modulates the frequency, rate, or extent of cell adhesion mediated by integrin.
	GO:0010591	regulation of lamellipodium assembly	Any process that modulates the rate, frequency or extent of the formation of a lamellipodium, a thin sheetlike extension of the surface of a migrating cell.
	GO:0070848	response to growth factor	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.
	GO:0001501	skeletal system development	The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
	GO:0001570	vasculogenesis	The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes.
	GO:0016032	viral process	A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.
cellular component
	GO:0030054	cell junction	A cellular component that forms a specialized region of connection between two or more cells or between a cell and the extracellular matrix. At a cell junction, anchoring proteins extend through the plasma membrane to link cytoskeletal proteins in one cell to cytoskeletal proteins in neighboring cells or to proteins in the extracellular matrix.
	GO:0042995	cell projection	A prolongation or process extending from a cell, e.g. a flagellum or axon.
	GO:0009986	cell surface	The external part of the cell wall and/or plasma membrane.
	GO:0005925	focal adhesion	Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments.
	GO:0016021	integral component of membrane	The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0005887	integral component of plasma membrane	The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0005622	intracellular	The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm.
	GO:0031258	lamellipodium membrane	The portion of the plasma membrane surrounding a lamellipodium.
	GO:0031256	leading edge membrane	The portion of the plasma membrane surrounding the leading edge of a motile cell.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
	GO:0032587	ruffle membrane	The portion of the plasma membrane surrounding a ruffle.

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		CL	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NA	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NAG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Gly A:171 - Pro A:172	[ RasMol ]
		His A:46 - Pro A:47	[ RasMol ]

Biological Units
	Complete Structure
		Biological Unit 1	[ Jena3D ]
		Biological Unit 2	[ Jena3D ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym. Unit PNG format \| Asym. Unit - sites PNG format \| Biol. Unit 1 PNG format \| Biol. Unit 1 - sites PNG format \| Biol. Unit 2 PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	3fl7
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	EPHA2_HUMAN \| P29317
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	2.7.10.1
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	(no 'MIM ID' available)
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	EPHA2_HUMAN \| P29317
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

1mqb	CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE
3c8x	CRYSTAL STRUCTURE OF LIGAND BINDING DOMAIN OF HUMAN EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE
3czu	CRYSTAL STRUCTURE OF HUMAN EPHRIN A2- EPHRIN A1 COMPLEX

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (3, 5)

Sites (4, 4)

SS Bonds (10, 10)

Cis Peptide Bonds (2, 2)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (3, 3)

PROSITE Motifs (4, 5)

Exons (8, 8)

Sequences/Alignments

Classification and Annotation

SCOP Domains (0, 0)

CATH Domains (0, 0)

Pfam Domains (0, 0)

Gene Ontology (62, 62)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File